Journal article
Evaluation of the Roche MagNA Pure 96 nucleic acid extraction platform for the Seegene Anyplex II HPV28 detection assay
Journal of Applied Microbiology, Vol.131(5), pp.2592-2599
2021
PMID: 33942451
Abstract
Aim: Validate the Roche, MagNAPure96 (MP96) nucleic acid extraction platform for Seegene Anyplex II HPV28 (Anyplex28) detection of Human Papillomavirus.
Methods and Results: Comparisons were made for Anyplex28 genotyping from 115 cervical samples extracted on the Hamilton, STARlet and the MP96. Two DNA concentrations were used for the MP96, one matched for sample input to the STARlet and another 5x concentration (laboratory standard). Agreement of HPV detection was 89 center dot 8% (kappa = 0 center dot 798; P = 0 center dot 007), with HPV detected in 10 more samples for the MP96. There was a high concordance of detection for any oncogenic HPV genotype (kappa = 0 center dot 77; P = 0 center dot 007) and for any low-risk HPV genotype (kappa = 0 center dot 85; P = 0 center dot 008). DNA extracted at laboratory standard had a lower overall agreement 85 center dot 2% (kappa = 0 center dot 708; P < 0 center dot 001), with 17/115 discordant positive samples that tested negative after STARlet extraction. Of the discordant genotypes, 72 center dot 7% were detected in the lowest signal range for Anyplex28 ('+').
Conclusions: MP96 performed with high concordance to STARlet, although produced DNA with a higher analytical sensitivity on the Anyplex28.
Significance and Impact of the Study: This analysis supports the use of samples extracted on the MP96 for HPV genotyping using the Anyplex28. Furthermore, an increase in DNA concentration increased analytical sensitivity of the Anyplex28, particularly appropriate for prevalence studies.
Details
- Title
- Evaluation of the Roche MagNA Pure 96 nucleic acid extraction platform for the Seegene Anyplex II HPV28 detection assay
- Authors
- S Atchison (Author) - Royal Women's HospitalH Shilling (Author) - Royal Womens Hosp, Ctr Womens Infect Dis, Melbourne, Vic, AustraliaP Balgovind (Author) - Royal Women's HospitalD. A Machalek (Author) - The University of MelbourneD Hawkes (Author) - AGRF LtdS. M Garland (Author) - Royal Womens Hosp, Ctr Womens Infect Dis, Melbourne, Vic, AustraliaM Saville (Author) - University of MalayaG Murray (Author) - Swinburne University of TechnologyM Molano (Author) - Royal Women's HospitalJ Danielewski (Author) - Royal Women's HospitalS Phillips (Corresponding Author) - Royal Women's Hospital
- Publication details
- Journal of Applied Microbiology, Vol.131(5), pp.2592-2599
- Publisher
- Wiley-Blackwell Publishing Ltd.
- Date published
- 2021
- DOI
- 10.1111/jam.15126
- ISSN
- 1365-2672; 1364-5072
- PMID
- 33942451
- Organisation Unit
- Centre for Bioinnovation
- Language
- English
- Record Identifier
- 99640379102621
- Output Type
- Journal article
Metrics
69 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Web Of Science research areas
- Biotechnology & Applied Microbiology
- Microbiology
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites